The anti-inflammatory effects of the neuronal nicotinic receptor alpha7 (nAChRα7) are proposed to require acetylcholine release from vagal efferents. The necessity for vagal innervation in this anti-inflammatory pathway was tested in the skin, which lacks parasympathetic innervation, using ultraviolet radiation (UVB) to induce a local pro-inflammatory response. Cytokine responses to UV in mice administered chronic oral nicotine, a nAChR agonist, were reduced. Conversely, nAChRα7 knock-out mice exposed to UVB elicit an enhanced pro-inflammatory cytokine response in the skin. Altered pro-inflammatory responses correlated with changes in SOCS3 protein. These results demonstrate that nAChRα7 can participate in modulating a local pro-inflammatory response in the absence of parasympathetic innervation.
Introduction
Neuronal nicotinic acetylcholine receptors (nAChR) have been extensively characterized for their function in peripheral and central neurons where they play a role in modulating neurotransmission (Alkondon and Albuquerque, 2004; Hogg et al., 2003) . However, nAChRs are also expressed by non-neuronal cells throughout the body where they contribute to diverse physiological processes including immunomodulation (Fujii et al., 2007) . Mature nAChRs are pentamers of subunit assemblages from 11 genetically related but distinct subunits (Hogg et al., 2003) . In general there are two major nAChRs subtypes that are composed of either homomeric subunits (e.g., nAChRα7) or combinations of alpha (α) and beta (β) subunits, and it is the final subunit configuration that imparts significant functional and pharmacological differences among these receptors. The response of nAChRs to nicotine has been particularly well-examined since it initiates the chemical dependency to tobacco products. However, nicotine also exhibits anti-inflammatory properties in many systems (de Jonge et al., 2005; Metz and Tracey, 2005; Pavlov et al., 2003; Sopori et al., 1998) . Among the earliest findings was the observation that nAChRα7 activation altered the capacity of cells to respond to the pro-inflammatory cytokine tumor necrosis factor alpha (TNFα) (Carlson et al., 1998) or inhibited the release of this cytokine from the cell (Metz and Tracey, 2005) . These studies have collectively defined an interaction described as the cholinergic anti-inflammatory pathway (Metz and Tracey, 2005; Pavlov et al., 2003) . As defined in these reviews, however, the anti-inflammatory properties of acetylcholine (or nicotine) are generally restricted to nAChRα7 Journal of Neuroimmunology 193 (2008) 130 -139 www.elsevier.com/locate/jneuroim Abbreviations: nAChR; neuronal nicotinic acetylcholine receptor; α7, alpha 7; UVR; ultraviolet radiation; IL-1β; interleukin 1 beta; IL-6; interleukin 6; TNFα; tumor necrosis factor alpha; SOCS3; suppressor of cytokine signaling 3; KO; knock-out. 
